Secondary Prevention Therapies for AMI Part 2: Thrombin Receptor Antagonists - Ori Ben-Yehuda, MD

↳ This is a section part of Moment: CRT 2015 - Satellite Symposium: Novel Therapeutic Pathways in the Secondary Prevention of Atherothrombotic Events in AMI

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$3.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Secondary Prevention Therapies for AMI Part 2: Thrombin  Receptor Antagonists presented by Ori Ben-Yehuda, MD at CRT 2015

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$3.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Interventional Fellows

Sponsored by the Cardiovascular Research Foundation through an educational grant from Merck & Company

Session Name: Satellite Symposium: Novel Therapeutic Pathways in the Secondary Prevention of Atherothrombotic Events in AMI

Learning Objectives

  • Update in advances in the Prevention of Atherothrombotic Events in AMI

Other Components in this Moment

Overview
Secondary Prevention Therapies for AMI Part I: Aspirin an ADP Antagonists - Deepak Bhatt, MD
Secondary Prevention Therapies for AMI Part 2: Thrombin Receptor Antagonists - Ori Ben-Yehuda, MD
Loading Simple Education